September 10, 2012
SpectraScience (SCIE) to Present at Rodman & Renshaw
SpectaScience Inc. (OTCBB: SCIE), a developer of light-based diagnostic technology for cancer identification, similar to companies like Verisante Technology Inc. (CVE: VRS) and MELA Sciences Inc. (NASDAQ: MELA), recently announced that it would be presenting at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, September 11th.
The presentation comes shortly after the company completed initial WavSTAT4 installation and training with PENTAX Europe, setting the stage for its first significant revenues. Investors are hoping that combination of this development and the investor presentation will help unlock value in the company’s stock over the coming quarters.
SpectraScience, Inc. (SCIE), a San Diego based medical device company, today announced that Chief Executive Officer Michael Oliver will be presenting at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, September 11, at 10:25 a.m. Eastern. The conference is being held at Waldorf Astoria Hotel in New York City.
A webcast of the Company’s presentation can be found at: http://www.wsw.com/webcast/rrshq22/scie
About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With approval for sale under the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.
Please read our Full Disclaimer pertaining to this article.